Circulating Tumor Cell Market Updates 2024 : Asia-Pacific is anticipated to Grow at the Highest CAGR During 2021-2031
North America acquired the major circulating tumor cell market share of the circulating tumor cell market in 2021.
WILMINGTON, DELAWARE , UNITED STATES, June 18, 2024 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Circulating Tumor Cell Market by Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, CTC Analysis), by Application (Clinical, Research), by End Users (Hospital and Clinics, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global circulating tumor cell industry generated $1.1 billion in 2021, and is anticipated to generate $5.9 billion by 2031, witnessing a CAGR of 18.0% from 2022 to 2031.
Circulating tumor cells (CTCs) are cells that detach from primary tumors and circulate in the patient's bloodstream. Recently, CTCs have been recognized as valuable biomarkers for the prognostic, diagnostic, and therapeutic response monitoring of cancer patients. These cells are rare, typically found at a concentration of one CTC per milliliter of peripheral blood, amidst approximately 1 million white blood cells and 1 billion red blood cells. Due to their rarity, detecting CTCs presents significant challenges. However, advancements in detection techniques, particularly those using integrated microfluidics and nanomaterial-based platforms, have improved selectivity and simplified the detection process.
๐น๐๐๐๐๐๐ ๐บ๐๐๐๐๐ ๐ช๐๐๐ ๐๐ ๐๐๐ ๐น๐๐๐๐๐ ๐ฏ๐๐๐ https://www.alliedmarketresearch.com/request-sample/A11918
The major trends driving the growth of the circulating tumor cell market include the rising number of cancer cases globally. CTC detection is primarily used for early cancer diagnosis, making these techniques increasingly important for cancer diagnosis and prognosis. Consequently, there is a growing demand for products such as kits and instruments used in CTC detection, further expanding the market.
Technological advancements in diagnostics and treatment, an increase in the number of cancer cases, greater awareness about CTCs and their role in cancer diagnosis, and a rise in research and development activities and clinical trials are driving the growth of the global circulating tumor cell market. However, the high cost associated with CTC testing, due to the expensive instruments required, is expected to hinder market growth. On the other hand, increased investment by key market players in developing countries and the adoption of various strategic initiatives by these players are anticipated to present new opportunities in the coming years.
Based on application, the clinical segment held the highest market share in 2021, accounting for more than two-thirds of the global circulating tumor cell market, and is expected to maintain its leadership status throughout the forecast period. This dominance is due to the increasing adoption of CTC detection techniques in cancer diagnosis and the rising number of cancer cases, including breast, prostate, and colon cancer. However, the research segment is projected to exhibit the highest compound annual growth rate (CAGR) of 18.6% from 2022 to 2031, driven by a surge in research and development activities focused on CTC detection and cancer diagnosis.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ- https://www.alliedmarketresearch.com/purchase-enquiry/A11918
๐๐๐๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ: -
Miltenyi Biotec
Precision Medicine Group LLC
Menarini Group
SRI International
Biocept, Inc.
QIAGEN
Greiner AG
Sysmex Corporation
Thermo Fisher Scientific Inc.
STEMCELL Technologies Inc.
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
๐๐๐ฌ๐ฉ๐ข๐ซ๐๐ญ๐จ๐ซ๐ฒ ๐๐ข๐ฌ๐ฉ๐จ๐ฌ๐๐๐ฅ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/respiratory-disposables-market-A11235
๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/sarcopenia-treatment-market-A10526
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
![](https://www.einnews.com/tracking/article.gif?aid=720903866§ion=einpresswire&a=XI15IF01dE8oKCCX&i=J4a9VPuipM6YBAT-)